Temple University Hospital performs nation's 1st post-FDA approval BLVR using Zephyr Valve

(Temple University Health System) Temple University Hospital has become the first US center to perform bronchoscopic lung volume reduction using implantation of the Zephyr ® Endobronchial Valve (Zephyr ® EBV ® ) to treat severe emphysema following US FDA approval.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news